{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T11:01:23Z","timestamp":1787742083730,"version":"build-2784847793"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.01370","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T04:30:12Z","timestamp":1508819412000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis"],"prefix":"10.3389","volume":"8","author":[{"given":"Sapna","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clas","family":"Malmestr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Meisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Verolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Yngve","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000065639","article-title":"Epidemiology of myasthenia gravis: a population-based study in Stockholm, Sweden","volume":"21","author":"Kalb","year":"2002","journal-title":"Neuroepidemiology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1067\/S0022-3476(03)00300-7","article-title":"Successful treatment of refractory myasthenia gravis using rituximab: a pediatric case report","volume":"143","author":"Wylam","year":"2003","journal-title":"J Pediatr"},{"key":"B4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1586\/1744666X.2015.1047345","article-title":"The role of T regulatory cells in immunopathogenesis of myasthenia gravis: implications for therapeutics","volume":"11","author":"Alahgholi-Hajibehzad","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ana.21901","article-title":"Specific immunotherapy of experimental myasthenia gravis by a novel mechanism","volume":"67","author":"Luo","year":"2010","journal-title":"Ann Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jnnp.65.4.492","article-title":"Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England","volume":"65","author":"Robertson","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.12688\/f1000research.8206.1","article-title":"Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms [version 1; referees: 2 approved]","volume":"5","author":"Phillips","year":"2016","journal-title":"F1000Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: a changing scene","volume":"56","author":"Aarli","year":"1999","journal-title":"Arch Neurol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ensci.2016.02.004","article-title":"Late-onset myasthenia gravis is predisposed to become generalized in the elderly","volume":"2","author":"Sakai","year":"2016","journal-title":"eNeurologicalSci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"3","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"B12","doi-asserted-by":"publisher","first-page":"404053","DOI":"10.1155\/2013\/404053","article-title":"Recent advances in genetic predisposition of myasthenia gravis","volume":"2013","author":"Zagoriti","year":"2013","journal-title":"Biomed Res Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","article-title":"Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States","volume":"38","author":"Deitiker","year":"2011","journal-title":"Int J Immunogenet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"541760","DOI":"10.1155\/2012\/541760","article-title":"Association of HLA-DQB1 *05:02 and DRB1 *16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"403915","DOI":"10.1155\/2012\/403915","article-title":"A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts","volume":"2012","author":"Vaughan","year":"2012","journal-title":"Autoimmune Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro \u2013 >Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2796.2007.01879.x","article-title":"Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis","volume":"263","author":"Wang","year":"2008","journal-title":"J Intern Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.clim.2008.05.006","article-title":"Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis","volume":"128","author":"Gu","year":"2008","journal-title":"Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nri2889","article-title":"Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases","volume":"10","author":"Buckner","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5656","DOI":"10.4049\/jimmunol.0903183","article-title":"Naturally occurring CD4+CD25+ regulatory T cells prevent but do not improve experimental myasthenia gravis","volume":"185","author":"Nessi","year":"2010","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1749-6632.1998.tb10936.x","article-title":"T cell recognition of the acetylcholine receptor in myasthenia gravis","volume":"841","author":"Conti-Fine","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.4049\/jimmunol.176.7.4012","article-title":"Induction of peripheral T cell tolerance by antigen-presenting B cells. I. Relevance of antigen presentation persistence","volume":"176","author":"Raimondi","year":"2006","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/08916939809008038","article-title":"T cell responses in EAMG-susceptible and non-susceptible mouse strains after immunization with overlapping peptides encompassing the extracellular part of Torpedo californica acetylcholine receptor alpha chain. Implication to role in myasthenia gravis of autoimmune T-cell responses against receptor degradation products","volume":"27","author":"Oshima","year":"1998","journal-title":"Autoimmunity"},{"key":"B27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/08916930008995987","article-title":"T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses","volume":"32","author":"Oshima","year":"2000","journal-title":"Autoimmunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5852","DOI":"10.1073\/pnas.89.13.5852","article-title":"Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide","volume":"89","author":"Atassi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1365-2567.2006.02398.x","article-title":"A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis","volume":"118","author":"Aruna","year":"2006","journal-title":"Immunology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.04.018","article-title":"Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+ CD25+ regulatory cells","volume":"177","author":"Aruna","year":"2006","journal-title":"J Neuroimmunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nmd.2010.12.003","article-title":"Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in myasthenia gravis","volume":"21","author":"Ching","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"B34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0165-5728(00)00250-2","article-title":"T cell recognition of muscle acetylcholine receptor in ocular myasthenia gravis","volume":"108","author":"Wang","year":"2000","journal-title":"J Neuroimmunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/08916934.2011.611550","article-title":"T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients","volume":"45","author":"Oshima","year":"2012","journal-title":"Autoimmunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/08916930600738581","article-title":"Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis","volume":"39","author":"Deitiker","year":"2006","journal-title":"Autoimmunity"},{"key":"B37","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g","volume":"97","author":"Boyum","year":"1968","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"B38","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/507418a","article-title":"Immunology: a tolerant approach","volume":"507","author":"Garber","year":"2014","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.humimm.2004.09.015","article-title":"Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity","volume":"66","author":"Oshima","year":"2005","journal-title":"Hum Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/WNL.48.6.1638","article-title":"Reactivity of T cells from seronegative patients with myasthenia gravis to T cell epitopes of the human acetylcholine receptor","volume":"48","author":"Karni","year":"1997","journal-title":"Neurology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1749-6632.1998.tb10941.x","article-title":"Th1\u2009cells of myasthenia gravis patients recognize multiple epitopes on the muscle acetylcholine receptor alpha subunit","volume":"841","author":"Wang","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1002\/eji.1830201206","article-title":"Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit","volume":"20","author":"Oshima","year":"1990","journal-title":"Eur J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1006\/cimm.1997.1171","article-title":"T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide","volume":"180","author":"Kirshner","year":"1997","journal-title":"Cell Immunol"},{"key":"B44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1615\/CritRevImmunol.v32.i3.10","article-title":"Non-MHC genes linked to autoimmune disease","volume":"32","author":"Deitiker","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1086\/380997","article-title":"Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans","volume":"74","author":"Oksenberg","year":"2004","journal-title":"Am J Hum Genet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/j.1468-1331.2008.02130.x","article-title":"Monitoring treatment with cyclosporine microemulsion in myasthenia gravis","volume":"15","author":"Utsugisawa","year":"2008","journal-title":"Eur J Neurol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000319172","article-title":"Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients","volume":"64","author":"Nagane","year":"2010","journal-title":"Eur Neurol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1365-3083.2012.02703.x","article-title":"T helper type 17 cells expand in patients with myasthenia-associated thymoma","volume":"76","author":"Wang","year":"2012","journal-title":"Scand J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-5728(94)90044-2","article-title":"Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells","volume":"50","author":"Yi","year":"1994","journal-title":"J Neuroimmunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0123546","DOI":"10.1371\/journal.pone.0123546","article-title":"Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK","volume":"10","author":"Yilmaz","year":"2015","journal-title":"PLoS One"},{"key":"B51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exphem.2016.09.008","article-title":"Clinical grade regulatory T cells: comparative analysis of large-scale expansion conditions","volume":"45","author":"Velaga","year":"2017","journal-title":"Exp Hematol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","article-title":"Restoring regulatory T cells in type 1 diabetes","volume":"16","author":"Spence","year":"2016","journal-title":"Curr Diab Rep"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.4049\/jimmunol.1600242","article-title":"Role of metabolism in the Immunobiology of regulatory T cells","volume":"197","author":"Galgani","year":"2016","journal-title":"J Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2249.1998.00521.x","article-title":"Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals","volume":"111","author":"Shi","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1172\/JCI8121","article-title":"Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment","volume":"104","author":"Im","year":"1999","journal-title":"J Clin Invest"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1172\/JCI116024","article-title":"Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor","volume":"90","author":"Protti","year":"1992","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12974-016-0678-4","article-title":"Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system","volume":"13","author":"Sinmaz","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J Neuroinflammation"},{"key":"B59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaut.2013.12.005","article-title":"Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis","volume":"52","author":"Yi","year":"2014","journal-title":"J Autoimmun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1054\/jocn.2001.1028","article-title":"Cytokine secretion by peripheral blood mononuclear cells in myasthenia gravis","volume":"9","author":"Yoshikawa","year":"2002","journal-title":"J Clin Neurosci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1046\/j.1468-1331.2000.00056.x","article-title":"Decreased mRNA expression of TNF-alpha and IL-10 in non-stimulated peripheral blood mononuclear cells in myasthenia gravis","volume":"7","author":"Huang","year":"2000","journal-title":"Eur J Neurol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2009.10.040","article-title":"Clinical implications of the type 1\/type 2 balance of helper T cells and P-glycoprotein function in peripheral T lymphocytes of myasthenia gravis patients","volume":"627","author":"Masuda","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1196\/annals.1254.032","article-title":"T cells and cytokines in the pathogenesis of acquired myasthenia gravis","volume":"998","author":"Milani","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"B65","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1046\/j.1365-2249.1999.01062.x","article-title":"Increased levels of circulating acetylcholine receptor (AChR)-reactive IL-10-secreting cells are characteristic for myasthenia gravis (MG)","volume":"118","author":"Huang","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneuroim.2007.12.008","article-title":"Clinical efficacy and cytokine network-modulating effects of tacrolimus in myasthenia gravis","volume":"195","author":"Furukawa","year":"2008","journal-title":"J Neuroimmunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01370\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T06:48:14Z","timestamp":1526280494000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.01370\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2017.01370"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.01370","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,24]]},"article-number":"1370"}}